eMedicine Specialties > Urology > Common Problems of the Urethra

Urethritis: Differential Diagnoses & Workup

Author: Martha K Terris, MD, FACS, Professor, Department of Surgery, Medical College of Georgia
Coauthor(s): Kamran P Sajadi, MD, Staff Physician, Division of Urology, Medical College of Georgia Health System
Contributor Information and Disclosures

Updated: Aug 10, 2009

Differential Diagnoses

Acute Bacterial Prostatitis and Prostatic Abscess
Mycoplasma Infections
Arthritis as a Manifestation of Systemic Disease
Oophoritis
Bacterial Cystitis
Papillomavirus
Chancroid
Pelvic Inflammatory Disease
Chlamydial Genitourinary Infections
Proctitis and Anusitis
Chlamydial Pneumonias
Prostatitis, Bacterial
Condyloma Acuminatum
Salpingitis
Dermatologic Diseases of the Male Genitalia: Malignant
Syphilis
Dermatologic Diseases of the Male Genitalia: Nonmalignant
Trichomoniasis
Epididymitis
Ureaplasma Infection
Gardnerella
Urethral Cancer
Gonococcal Arthritis
Urethral Caruncle
Gonococcal Infections
Urethral Diverticula
Herpes Simplex
Urethral Diverticulum
Human Papillomavirus
Urethral Strictures
Infertility
Urethral Syndrome
Molluscum Contagiosum
Urethral Trauma
Mycobacterium Gordonae
Urethral Warts
Mycobacterium Haemophilum
Vaginitis
Mycobacterium Kansasii
Vulvovaginitis

Other Problems to Be Considered

Trichomonal vaginitis
Candidal vaginitis
Alcohol ingestion
Contact dermatitis secondary to spermicides
Guilt over sexual behavior likely to be perceived as deviant
Guilt over infidelity
Dried semen mistaken for discharge
Stevens-Johnson syndrome
Foreign body
Fungal infections of the genitourinary tract

Workup

Laboratory Studies

Urethritis can be diagnosed based on the presence of one or more of the following: (1) a mucopurulent or purulent urethral discharge, (2) urethral smear that demonstrates at least 5 leukocytes per oil immersion field on microscopy, and (3) first-voided urine specimen that demonstrates leukocyte esterase on dipstick test or at least 10 white blood cells (WBCs) per high-power field on microscopy.

All patients with urethritis should be tested for N gonorrhoeae and C trachomatis.

  • Gram stain
    • Traditionally, treatment was based on Gram stain results. Patients with gram-negative intracellular diplococci on urethral smear received treatment for gonococcal urethritis, and those without gram-negative intracellular diplococci received treatment for nongonococcal urethritis (NGU).
    • Because current recommendations suggest patients receive concomitant treatment for both, and with the success of nucleic acid amplification tests (NAATs), a Gram stain may be unnecessary.
  • Urethral culture for N gonorrhoeae and C trachomatis
    • Endourethral culture (obtained by gently inserting a malleable cotton-tipped swab 1-2 cm into the urethra), rather than culture of the expressible discharge, is necessary to test for C trachomatis infection. Endocervical cultures should also be obtained in women.
    • This culture may be a useful screening tool for penicillinase-producing N gonorrhoeae or chromosomally mediated resistance to multiple antibiotics; however, the results do not influence the initial antibiotic therapy, and performing this screening may not be cost-effective.
  • Urine
    • Urinalysis is not a useful test in patients with urethritis, except for helping exclude cystitis or pyelonephritis, which may be necessary in cases of dysuria without discharge. Patients with gonococcal urethritis may have leukocytes in a first-void urine specimen and fewer or none in a midstream specimen. More than 30% of patients with NGU do not have leukocytes in urine specimens.
    • Many nucleic acid–based tests for C trachomatis and N gonorrhoeae can be performed on urine specimens (see below). These require a first-voided specimen. For Chlamydia species, endourethral samples are more accurate.
  • Nucleic acid amplification tests
    • Polymerase chain reaction assays are available for gonococcal urethritis and Chlamydia infection. NAATs are also available for Mycoplasma species, Ureaplasma species, and T vaginalis, but these are not recommended, as they are expensive and do not alter the choice of treatment.
    • NAATs are the preferred test for Chlamydia and are more sensitive than traditional culture methods. Chlamydia DNA probe results are 60%-70% sensitive and nearly 100% specific. Obtain samples on swabs at least 2 hours after micturition, using a calcium-alginate swab on a nonwooden stick inserted at least 1 cm in depth to help prevent false-negative findings. Chlamydia ligase chain reaction is 90%-95% sensitive and nearly 100% specific. Obtain samples on swabs at least 2 hours after micturition, using a calcium-alginate swab on a nonwooden stick inserted at least 1 cm in depth to help prevent false-negative results.
    • DNA-based tests, unlike culture, do not allow for antibiotic susceptibility testing, but this is unnecessary in most patients.
  • Potassium hydroxide preparation: This is used to evaluate for fungal organisms.
  • Wet preparation: Secretions reveal the movement of trichomonal organisms, if present.
  • STD testing: Patients with urethritis should be counseled about the risk for more serious STDs. They should be offered syphilis serology (Venereal Disease Research Laboratory test or Rapid Plasma Reagin test) and HIV serology.
  • Nasopharyngeal and/or rectal swabs: Men who have sex with men (and perhaps other patients) should undergo gonorrhea screening with nasopharyngeal and/or rectal swabs. Validation of NAATs for these specimens is still in progress.1
  • Pregnancy testing: Women who have had unprotected intercourse should be offered pregnancy testing.
  • Other tests: Patients with reactive arthritis are diagnosed based on the presence of NGU and clinical findings of uveitis and arthritis. HLA-B27 testing is of limited value. More readily available laboratory findings, such as elevated erythrocyte sedimentation rate (ESR) in the absence of rheumatoid factor, may be helpful.

Imaging Studies

  • Imaging studies, specifically retrograde urethrography, are unnecessary in patients with urethritis, except in cases of trauma or possible foreign body insertion.

Procedures

  • Catheterization
    • In cases of urethral trauma, urethral catheter placement can hold the urethra open to avoid urinary retention caused by edema or a flap of elevated mucosa.
    • The catheter also serves to tamponade urethral bleeding.
  • Cystoscopy
    • When urethral catheter placement is not possible after urethral trauma, careful negotiation of the urethra with a flexible cystocope can allow passage of a guidewire, over which the Council tip urethral catheter can be placed. This can generally be performed in the emergency department or outpatient clinic with local anesthesia (lidocaine jelly). However, if not easily accomplished on the initial attempt, this procedure should be aborted to avoid further urethral trauma, and a suprapubic tube should be placed.
    • A foreign body or stone in the urethra, which may mimic urethritis, can be removed cystoscopically. Unless the object is very small and very distal, this procedure probably should be undertaken in the operating suite while the patient is under anesthesia. A rigid cystoscope with a larger lumen sheath and working port allows utilization of more secure endoscopic graspers. The object can often be removed through the large lumen of the cystoscope sheath, rather than pulling it through the distal urethra (which may cause further trauma).
  • Filiforms and followers: Filiforms and followers can also be used by experienced urologists but are being used less frequently in cases of urethral trauma because of the wide availability of flexible cystoscopes. In addition, this technique can lead to more severe urethral trauma if not used correctly.
  • Suprapubic tube placement: With more severe urethral trauma preventing urethral catheter placement or inadequate facilities for emergent cystoscopy in patients with urethral obstruction due to trauma or foreign bodies, a suprapubic catheter is an excellent temporizing measure to divert urine and relieve patient discomfort until definitive therapy can be undertaken.

More on Urethritis

Overview: Urethritis
Differential Diagnoses & Workup: Urethritis
Treatment & Medication: Urethritis
Follow-up: Urethritis
References

References

  1. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. Nov 2008;35(11):946-59. [Medline].

  2. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE. 2008;3(11):e3618. [Medline].

  3. Gunn RA, O'Brien CJ, Lee MA, Gilchick RA. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997-2003. Sex Transm Dis. Oct 2008;35(10):845-8. [Medline].

  4. Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect. Dec 2005;81(6):458-62. [Medline].

  5. Frenkl T and Potts J. Sexually Transmitted Diseases. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, Pa: Saunders; 2006:371-85.

  6. Centers for Disease Control and Prevention. CDC Division of AIDS, STD, and TB. Gonococcal Isolation Surveillance Project (GISP) Annual Report - 2007. Atlanta, Ga: Centers for Disease Control and Prevention[Full Text].

  7. [Guideline] Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55:1-94. [Medline].

  8. Chorba T, Tao G, Irwin K. Sexually Transmitted Diseases. In: Litwin MS, Saigal CS, eds. Urologic Diseases in America. 2004;233-79. [Full Text].

  9. Cunningham KA, Beagley KW. Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod. Aug 2008;79(2):180-9. [Medline].

  10. Frenkl T, Potts J. Sexually Transmitted Infections: Part II - Associated Vaginitides and Urethritides. AUA Update Series. 2006;25:17-9.

  11. Isselbacher HK, Braunwald E, Wilson JD et al, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill; 1994.

  12. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin Treatment Failure in Mycoplasma genitalium-Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance. Clin Infect Dis. Dec 15 2008;47(12):1546-1553. [Medline].

  13. Kataria RK, Brent LH. Spondyloarthropathies. Am Fam Physician. Jun 15 2004;69(12):2853-60. [Medline].

  14. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. New York, NY: Churchill Livingstone; 1998.

  15. National Institute of Allergy and Infectious Diseases. Fact Sheet. STD Statistics. Bethesda, Md: National Institutes of Health; December 1998[Full Text].

  16. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. Apr 1 2007;44 Suppl 3:S84-101. [Medline].

  17. Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia. Apr 2008;40(2):72-5. [Medline].

  18. [Guideline] Workowski KA, Levine WC. Selected topics from the Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines 2002. HIV Clin Trials. Sep-Oct 2002;3(5):421-33. [Medline][Full Text].

Further Reading

Keywords

urethritis, gonococcal urethritis, nongonococcal urethritis, NGU, GU, urethral inflammation, urethra inflammation, infected urethra, STD, sexually transmitted disease, Neisseria gonorrhoeae, N gonorrhoeae, Chlamydia trachomatis, C trachomatis, Ureaplasma urealyticum, U urealyticum, Mycoplasma hominis, M hominis, Trichomonas vaginalis, T vaginalis, Mycobacterium, lymphogranuloma venereum, herpes genitalis, genital herpes, syphilis, mycobacteria, cystitis, urethral stricture, post-traumatic urethritis, posttraumatic urethritis, foreign body insertion, epididymitis, orchitis, prostatitis, proctitis, Reiter syndrome, iritis, pneumonia, otitis media, urinary tract infection, UTI, pelvic inflammatory disease, PID, disseminated gonococcal infection, DGI, infectious urethritis

Contributor Information and Disclosures

Author

Martha K Terris, MD, FACS, Professor, Department of Surgery, Medical College of Georgia
Martha K Terris, MD, FACS is a member of the following medical societies: American Cancer Society, American College of Surgeons, American Institute of Ultrasound in Medicine, American Urological Association, New York Academy of Sciences, and Society of University Urologists
Disclosure: Nothing to disclose.

Coauthor(s)

Kamran P Sajadi, MD, Staff Physician, Division of Urology, Medical College of Georgia Health System
Kamran P Sajadi, MD is a member of the following medical societies: American Urological Association, Endourological Society, and National Association for Continence
Disclosure: Nothing to disclose.

Medical Editor

Leonard Gabriel Gomella, MD, FACS, The Bernard W Godwin Professor of Prostate Cancer Chairman, Department of Urology, Associate Director of Clinical Affairs, Kimmel Cancer Center, Thomas Jefferson University
Leonard Gabriel Gomella, MD, FACS is a member of the following medical societies: American Association for Cancer Research, American College of Surgeons, American Medical Association, American Society for Laser Medicine and Surgery, American Urological Association, Sigma Xi, Society for Basic Urologic Research, Society of University Urologists, and Society of Urologic Oncology
Disclosure: GSK Consulting fee Consulting; Astra Zeneca Honoraria Speaking and teaching; Watson Pharmaceuticals Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association
Disclosure: Lilly Consulting fee Consulting; Astellas Consulting fee Speaking and teaching; Indevus Consulting fee Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.